Publications
Author Correction: A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats
Julio CB Ferreira, Juliane C Campos, Nir Qvit, Xin Qi, Luiz HM Bozi, Luiz RG Bechara, Vanessa M Lima, Bruno B Queliconi, Marie-Helene Disatnik, Paulo MM Dourado, Alicia J Kowaltowski, Daria Mochly-Rosen, nature communications 15, 2024
[EVALUATION OF DIFFERENT TIMINGS OF EARLY CARDIAC REHABILITATION AFTER MYOCARDIAL INFARCTION AND EXAMINATION OF DRUG THERAPY BASED ON THE SYNTHESIZED PEPTIDE TO BALANCE THE MITOCHONDRIAL DYNAMICS PROCESSES].
O Ertracht, R Golan, S Atar, N Qvit, Harefuah 163 (2), 88-92, 2024
The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis
H Berhe, M Kumar Cinthakunta Sridhar, M Zerihun, N Qvit, Pharmaceutics 16 (2), 227, 2024
Studying Biomolecular Protein Complexes via Origami and 3D-Printed Models
H Azulay, I Benyunes, G Elber, N Qvit, International Journal of Molecular Sciences 25 (15), 8271, 2024
The Drp1-Mediated Mitochondrial Fission Protein Interactome as an Emerging Core Player in Mitochondrial Dynamics and Cardiovascular Disease Therapy
M Zerihun, S Sukumaran, N Qvit, International Journal of Molecular Sciences 24 (6), 5785, 2023
Selective inhibitors targeting Fis1/Mid51 protein-protein interactions protect against hypoxia-induced damage in cardiomyocytes.
Zerihun M, Qvit N, Frontiers in Pharmacology 14, 1275370, 2023
Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinoma.
Sukumaran S, Tan M, Ben-Uliel Fluss S, Zhang H, De Zotti M, Chua MS, So KS, Qvit N, Computational and Structural Biotechnology Journal 21, 3159-3172 , 2023
Developing a peptide to disrupt cohesin head domain interactions
Maria Elias, Samar Gani, Yana Lerner, Katreen Yamin, Chen Tor, Adarsh Patel, Avi Matityahu, Moshe Dessau, Nir Qvit, Itay Onn, iScience 26 (9), 2023
An update on protein kinases as therapeutic targets. Part I: Protein kinase C activation and its role in cancer and cardio-vascular diseases.
Silinsky S, Rubin S, Zerihun M, Qvit N, International Journal of Molecular Sciences 24 (24), 17600 , 2023
An update on protein kinases as therapeutic targets. Part II: Peptides as allosteric protein kinase C modulators targeting protein-protein interactions.
Zerihun M, Rubin S, Silinsky S, Qvit N, International Journal of Molecular Sciences 24 (24), 17504, 2023
A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury
Nir Qvit, Amanda J Lin, Aly Elezaby, Nicolai P Ostberg, Juliane C Campos, Julio CB Ferreira, Daria Mochly-Rosen, Pharmaceuticals 15 (3), 271, 2022
Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Y Lerner, S Sukumaran, MS Chua, SK So, N Qvit, JoVE (Journal of Visualized Experiments), e63495, 2022
De Novo Development of Mitochondria-Targeted Molecular Probes Targeting Pink1.
Ben-Uliel Fluss S, Zoabi Habrat F, Slavin M, Sibony-Benyamini H, Kalisman N, Qvit N, International Journal of Molecular Sciences 23 (11), 6076, 2022
Using field-effect biosensing technology to measure protein-protein interactions between molecular chaperone Hsp90 and protein kinase Cdc37.
Lerner Y * , Sukumaran S * , Chua MS, So SK, Qvit N, 2022